Flexible care in breast cancer

Por Wardley, A., Canon, J.-L., Elsten, L., Peña Murillo, C., Badovinac Crnjevic, T., Fredriksson, J., Piccart, M.
Publicado no ESMO Open (2021)

Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study

Por Kirschbrown, Whitney P., Wynne, Chris, Kågedal, Matts, Wada, Russ, Li, Hanbin, Wang, Bei, Nijem, Ihsan, Badovinac Crnjevic, Tanja, Gasser, Helena, Heeson, Sarah, Eng‐Wong, Jennifer, Garg, Amit
Publicado no J Clin Pharmacol (2018)

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

Por Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Publicado no Breast Cancer Res (2016)

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27

Por Strasser-Weippl, Kathrin, Higgins, Michaela J, Chapman, Judith-Anne W, Ingle, James N, Sledge, George W, Budd, George T, Ellis, Matthew J, Pritchard, Kathleen I, Clemons, Mark J, Badovinac-Crnjevic, Tanja, Han, Lei, Gelmon, Karen A, Rabaglio, Manuela, Elliott, Catherine, Shepherd, Lois E, Goss, Paul E
Publicado no J Natl Cancer Inst (2018)

Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial

Por Goss, Paul E, Hershman, Dawn L, Cheung, Angela M, Ingle, James N, Khosla, Sundeep, Stearns, Vered, Chalchal, Haji, Rowland, Kendrith, Muss, Hyman B, Linden, Hannah M, Scher, Judite, Pritchard, Kathleen I, Elliott, Catherine R, Badovinac-Crnjevic, Tanja, St Louis, Jessica, Chapman, Judith-Anne W, Shepherd, Lois E
Publicado no Lancet Oncol (2014)